Cite
HARVARD Citation
Han, B. et al. (n.d.). 396OA multi-center, randomized, double-blind, parallel, two-group phase III trial on the efficacy and safety of QL1101 or bevacizumab in combination with paclitaxel and carboplatin in first-line treatment of non-squamous non-small cell lung cancer. Annals of oncology. p. . [Online].